On this page
What each program costs in Texas
The monthly price is all-in: the drug plus a membership when we have verified one. Compounded drugs are not FDA-approved.
| # | Program | Cheapest product | Plan | All in | Membership fee | Trustpilot | Checked | Seller site |
|---|---|---|---|---|---|---|---|---|
| 1 | Compounded Semaglutide | sale price | $39/mo | not verified | too few reviews | Visit | ||
| 2 | Compounded Semaglutide | 12-month plan, $588 up front | $49/mo | none | 3.9 (11,798 reviews) | Visit | ||
| 3 | Compounded Semaglutide | month to month | $59/mo | none | too few reviews | Visit | ||
| 4 | Compounded Semaglutide | 12-month plan, $828 up front | $69/mo | none | 4.6 (4,268 reviews) | Visit | ||
| 5 | Compounded Semaglutide | medication monthly, membership yearly | $75/mo | $199/yr, included | 4.8 (288 reviews) | Visit | ||
| 6 | Compounded Semaglutide | month to month | $79/mo | none | too few reviews | Visit | ||
| 7 | Compounded Semaglutide | month to month | $99/mo | none | 4.6 (5,235 reviews) | Visit | ||
| 8 | Compounded Semaglutide | 12-month plan, $1,188 up front | $99/mo | none | 4.3 (880 reviews) | Visit | ||
| 9 | Compounded Semaglutide | 12-month plan, $1,188 up front | $99/mo | none | 4.2 (218 reviews) | Visit | ||
| 10 | Compounded Semaglutide | 12-month plan, $1,260 up front | $105/mo | none | too few reviews | Visit | ||
| 11 | Compounded Semaglutide | 12-month plan, $1,698 up front | $141/mo | none | too few reviews | Visit | ||
| 12 | Semaglutide | month to month | $149/mo | none | too few reviews | Visit | ||
| 13 | Compounded Semaglutide | 12-month plan, $1,788 up front | $149/mo | none | 4.2 (777 reviews) | Visit | ||
| 14 | Microdosing Tirzepatide | 12-month plan, $2,028 up front | $169/mo | none | 4.0 (162 reviews) | Visit | ||
| 15 | Compounded Semaglutide | 2-month plan, $350 up front | $175/mo | none | 4.6 (1,084 reviews) | Visit | ||
| 16 | Compounded Oral Semaglutide Capsules | 6-month plan, $1,194 up front | $199/mo | none | too few reviews | Visit | ||
| 17 | Foundayo (brand orforglipron) | medication monthly, membership yearly | $208/mo | $59/mo, billed yearly, included | 4.6 (4,607 reviews) | Visit | ||
| 18 | Sublingual Semaglutide | month to month | $249/mo | none | 4.5 (17,622 reviews) | Visit | ||
| 19 | Compounded Semaglutide | month to month | $299/mo | none | too few reviews | Visit |
Does the HealthSelect of Texas (ERS state employee plan) cover GLP-1s for weight loss?
The HealthSelect of Texas plan document effective September 1, 2026 excludes prescription drugs for reducing obesity or weight, even with other health conditions. The exclusion does not apply to the plan's Wondr and Real Appeal weight programs.
HealthSelect of Texas (Blue Cross and Blue Shield of Texas)
The HealthSelect of Texas Master Benefit Plan Document effective September 1, 2026 lists weight-reduction prescription drugs among its exclusions.
“services or supplies for reduction of obesity or weight, including surgical procedures and prescription drugs, even if the Participant has other health conditions which might be helped by a reduction of obesity or weight, except for healthy diet counseling and obesity screening/counseling as may be provided under Preventive Care Services.”
https://healthselect.bcbstx.com/pdf/in-area-mbpd-py27.pdf · read Oct 29, 2026
HealthSelect of Texas (Blue Cross and Blue Shield of Texas)
The same document carves the plan's Wondr and Real Appeal weight programs out of that exclusion.
“This exclusion does not apply to: Covered HealthSelect weight loss programs, currently Wondr and Real Appeal;”
https://healthselect.bcbstx.com/pdf/in-area-mbpd-py27.pdf · read Oct 29, 2026
What do Texas's big insurers publish on Wegovy and Zepbound?
Blue Cross and Blue Shield of Texas
Blue Cross and Blue Shield of Texas treats GLP-1 weight-management coverage as an optional choice for employer groups. From November 1, 2026, self-funded groups with Prime Therapeutics that cover these drugs can set a $150 member cost share for up to a 30-day supply.
Blue Cross and Blue Shield of Texas
A May 2025 provider notice says weight-management GLP-1s are not a standard benefit, though some self-funded (ASO) groups add them.
“Coverage for GLP-1 weight management drugs, such as Saxenda, Wegovy and Zepbound, is not a standard benefit for members. Some ASO group plans may offer coverage for weight loss and/or weight management drugs as a custom benefit.”
https://www.bcbstx.com/provider/education/education/news/2025/5-20-2025-new-home-delivery-pharmacy-service-to-fill · read Oct 29, 2026
Blue Cross and Blue Shield of Texas
In a May 20, 2026 note for self-funded groups, Blue Cross and Blue Shield of Texas says GLP-1 weight-management coverage is optional for the plan.
“As with other GLP‑1s for weight management, plan coverage is optional with utilization management and metabolic health programs are available to drive safe and clinically appropriate use.”
https://www.bcbstx.com/producer/news/05-20-26-new-glp1-coverage-2026 · read Oct 29, 2026
Blue Cross and Blue Shield of Texas
An October 9, 2026 employer notice adds a $150 member cost-share option from November 1, 2026 for self-funded groups that cover these drugs.
“Beginning Nov. 1, 2026, self-funded groups with Prime Therapeutics® that cover GLP-1 weight-management drugs can elect a new, $150 member cost-share benefit.”
https://www.bcbstx.com/employer/news/10-09-26-greater-flexibility · read Oct 29, 2026
Does Texas Medicaid cover GLP-1s for weight loss?
Not covered for weight loss
Texas Medicaid's criteria cover Wegovy only for heart disease with overweight or obesity or for a liver condition, and Zepbound only for sleep apnea with obesity, so neither is covered for weight loss alone. Read from state documents Nov 6, 2026.
What Texas Medicaid's documents say about each drug for weight loss. Read Nov 6, 2026. Texas Health and Human Services Commission, Vendor Drug Program.
WegovyNo
Prior authorization. Covered uses: cardiovascular disease with obesity or overweight (age 45 or older), or non-cirrhotic MASH with moderate to advanced liver fibrosis (adults, injection only).
“Does the client have a diagnosis of cardiovascular disease (CVD) in past medical and/or pharmacy claims history?”
Texas HHSC Vendor Drug Program, Texas Prior Authorization Program criteria (Acentra Health) · No effective date on the document · read Nov 6, 2026
“formerly known as nonalcoholic steatohepatitis (NASH), in past medical and/or pharmacy claims history? [ ] Yes - Go to #6 [ ] No - Deny”
Texas HHSC Vendor Drug Program, Texas Prior Authorization Program criteria (Acentra Health) · No effective date on the document · read Nov 6, 2026
ZepboundNo
Prior authorization. Covered use: moderate to severe obstructive sleep apnea with obesity, adults only.
“Does the client have a diagnosis of moderate to severe obstructive sleep apnea (OSA) in past medical and/or pharmacy claims history? [ ] Yes - Go to #3 [ ] No - Deny”
Texas HHSC Vendor Drug Program, Texas Prior Authorization Program criteria (Acentra Health) · No effective date on the document · read Nov 6, 2026
OzempicNo
Prior authorization under the GLP-1 criteria, which require a type 2 diabetes diagnosis.
“Does the client have a diagnosis of type 2 diabetes in the last 365 days? [ ] Yes (Go to #4) [ ] No (Deny)”
Texas HHSC Vendor Drug Program, Texas Prior Authorization Program criteria (Acentra Health) · No effective date on the document · read Nov 6, 2026
“Does the client have a diagnosis of type 2 diabetes in past medical and/or pharmacy claims history? [ ] Yes - Go to #4 [ ] No - Deny”
Texas HHSC Vendor Drug Program, Texas Prior Authorization Program criteria (Acentra Health) · No effective date on the document · read Nov 6, 2026
“(And the request is for Ozempic, Trulicity or Victoza, go to #6)”
Texas HHSC Vendor Drug Program, Texas Prior Authorization Program criteria (Acentra Health) · No effective date on the document · read Nov 6, 2026
MounjaroNo
Prior authorization under the GLP-1 criteria, which require a type 2 diabetes diagnosis.
“Does the client have a diagnosis of type 2 diabetes in the last 365 days? [ ] Yes (Go to #4) [ ] No (Deny)”
Texas HHSC Vendor Drug Program, Texas Prior Authorization Program criteria (Acentra Health) · No effective date on the document · read Nov 6, 2026
“Does the client have a diagnosis of type 2 diabetes in past medical and/or pharmacy claims history? [ ] Yes - Go to #4 [ ] No - Deny”
Texas HHSC Vendor Drug Program, Texas Prior Authorization Program criteria (Acentra Health) · No effective date on the document · read Nov 6, 2026
“(And request is for Mounjaro, Trulicity, or Victoza) - Go to #2”
Texas HHSC Vendor Drug Program, Texas Prior Authorization Program criteria (Acentra Health) · No effective date on the document · read Nov 6, 2026
This reports what the documents say. It is not medical or legal advice: your plan and your prescriber decide.
What changed, and when
- Nov 6, 2026 · This pageFirst read from Texas Health and Human Services Commission, Vendor Drug Program documents. KFF's January 2026 map listed this program as not covered; the documents we read agree.
- Nov 24, 2025 · Policy changeAdded prior authorization criteria for Wegovy for MASH.
“Beginning November 24, 2025, Texas Medicaid and managed care organizations (MCOs) will require providers to get clinical prior authorization for the Wegovy MASH indication”
Texas Medicaid & Healthcare Partnership (TMHP) · Effective Nov 24, 2025 · read Nov 6, 2026
Weight loss
Not covered, read Nov 2026
Type 2 diabetes
Required in every state
Heart risk, sleep apnea
Required (Wegovy, Zepbound)
Prior authorization
Typical when covered
Wegovy, Zepbound, Saxenda, 2025
4,986 prescriptions
Ozempic and Mounjaro, 2025
141,062 prescriptions
Neighbours covering weight loss
0 of 4
Federal law lets each state decide whether Medicaid pays for drugs used for weight loss, while drugs approved for diabetes must be covered. A state document may not settle every plan; if your Texas Medicaid coverage comes through a managed care plan, its formulary can differ, so ask the plan before you fill.
For comparison, a dated secondary source: KFF's January 2026 map listed Texas Medicaid as "not covered" for GLP-1s for obesity under fee-for-service. Texas Medicaid covers one or more older weight-loss drugs, but no GLP-1.
The BALANCE model
CMS’s BALANCE model lets state Medicaid programs add GLP-1s for weight management at a negotiated price. States could join on a rolling basis from May 1, 2026 through January 1, 2027, and the state application deadline was July 31, 2026. We could not find a published list of the states that joined, so this page does not say whether Texas Medicaid did. Ask your plan. Either way your cost stays at Medicaid’s nominal copay, which BALANCE does not change.
The national picture, coupons and patient assistance: does Medicaid cover GLP-1s.
How many GLP-1s does Texas Medicaid pay for?
172,203 GLP-1 prescriptions in 2025, 17th of the 50 states and DC, with $172.7 million reimbursed before rebates. Counting the share other payers covered, $178.9 million.
Prescriptions, 2025
172,203
17th of 51
Medicaid paid
$172.7M
17th of 51, before rebates
Per prescription
$1,003
$1,051 nationally
Weight-loss brands
2.9%
29th highest share of 51
CMS State Drug Utilization Data 2025, updated Jul 13, 2026, fee-for-service and managed care, before rebates. Texas is highlighted. CMS publishes this comparison as one year, not a trend.
Wegovy, Zepbound and Saxenda, the brands approved for weight management, were 2.9% of Texas Medicaid's GLP-1 prescriptions in 2025 (4,986). Across the 13 states KFF lists as covering GLP-1s for obesity, the median share was 52%; across the other 38, 2.3%. Where weight loss is not covered, those brands are mostly filled for the uses Medicaid must cover, such as heart risk and sleep apnea. Ozempic was Texas Medicaid's most filled GLP-1.
| Brand | Prescriptions | Share | Medicaid paid | Per Rx |
|---|---|---|---|---|
| Ozempic | 92,318 | 54% | $90.1 million | $976 |
| Mounjaro | 48,744 | 28% | $51.4 million | $1,055 |
| Trulicity | 20,578 | 12% | $20.5 million | $994 |
| Wegovyapproved for weight management | 4,638 | 2.7% | $5.4 million | $1,157 |
| Rybelsus | 2,874 | 1.7% | $3.5 million | $1,216 |
| Liraglutide (generic) | 1,345 | 0.8% | $575,237 | $428 |
| Victoza | 1,083 | 0.6% | $673,787 | $622 |
| Zepboundapproved for weight management | 348 | 0.2% | $330,041 | $948 |
| Bydureon | 275 | 0.2% | $203,067 | $738 |
Source: CMS State Drug Utilization Data 2025, updated Jul 13, 2026, all four quarters, fee-for-service and managed care. Before rebates. CMS suppresses rows under 11 prescriptions, so small brands are undercounted slightly. Every state ranked: prescriptions and spending.
Which FDA-registered outsourcing facilities are in Texas?
FDA's register of 503B outsourcing facilities, updated Nov 17, 2026, lists 17 in Texas. The register does not say which, if any, supplies a program on this page.
- Apocus, Inc., San Antonio. Registered since Oct 17, 2023; not yet inspected by FDA.
- Arc Compounding Pharmacy, LLC, Waco. Registered since Jun 22, 2024; not yet inspected by FDA.
- Aspire Compounding Pharmacy, Sugar Land. Registered since Mar 21, 2025; not yet inspected by FDA.
- Atilar Pharma Corporation, Houston. Registered since Feb 20, 2025; not yet inspected by FDA.
- Empower Pharma, Houston. Registered since Jul 16, 2016; last FDA inspection Nov 14, 2025.
- Farmakeio Outsourcing LLC, Southlake. Registered since Dec 12, 2018; last FDA inspection Sep 5, 2025.
- Mark Cuban Cost Plus Manufacturing and Compounding, LLC, Dallas. Registered since Nov 2, 2022; last FDA inspection Sep 30, 2026.
- Maxhealth Group, LLC dba New Life Rx, Dallas. Registered since Apr 29, 2026; not yet inspected by FDA.
- Medicinal Sciences Ltd. Co., Heath. Registered since Sep 21, 2026; not yet inspected by FDA.
- Olyx Pharma, Schertz. Registered since Aug 3, 2026; not yet inspected by FDA.
- Quva Pharma, Inc., Sugar Land. Registered since Sep 10, 2015; last FDA inspection May 4, 2026.
- Right Value Drug Stores, LLC, dba Carie Boyd's Prescription Shop, Irving. Registered since Jul 3, 2019; last FDA inspection Sep 8, 2026.
- VitalRx Pharmacy, LLC, Houston. Registered since Aug 27, 2024; not yet inspected by FDA.
- Wells Pharma of Houston, LLC, Houston. Registered since Mar 9, 2020; last FDA inspection Apr 13, 2026.
- White Label Pharmacy dba Nova Pharmacy, Katy. Registered since Dec 16, 2025; not yet inspected by FDA.
- Wilcrest Pharmaceuticals, Inc., Houston. Registered since Mar 13, 2025; not yet inspected by FDA.
- Willowbend Pharma Select, LLC, Houston. Registered since Apr 11, 2024; not yet inspected by FDA.
On Medicare in Texas?
Medicare’s temporary GLP-1 Bridge works the same in every state: a $50 copay for a one-month supply of Wegovy, Foundayo or the Zepbound KwikPen, for people with Part D who meet its weight and health rules.
medicare.gov
“You’ll pay a $50 copayment to the pharmacy for a one-month supply (either 28 or 30 days, depending on drug).”
https://www.medicare.gov/coverage/weight-loss-drugs · read Nov 14, 2026
Texas and the states around it
Medicaid’s weight-loss answer (the state’s own documents where we have read them, otherwise KFF, January 2026) and the partner programs that ship there, priced the same way as above.
None of the 4 states next to Texas covers GLP-1s for weight loss through Medicaid. None has a lower cash floor than Texas's $39.
| State | Medicaid, weight loss | Ship there | Cheapest that ships there |
|---|---|---|---|
| Texas | Not covered | 19 | $39/mo |
| Arkansas | Not covered | 16 | $39/moWellmedr |
| Louisiana | Not covered | 13 | $39/moWellmedr |
| New Mexico | Not covered | 19 | $39/moWellmedr |
| Oklahoma | Not covered | 19 | $39/moWellmedr |






















